meclofenamic acid has been researched along with Experimental Neoplasms in 1 studies
Meclofenamic Acid: A non-steroidal anti-inflammatory agent with antipyretic and antigranulation activities. It also inhibits prostaglandin biosynthesis.
meclofenamic acid : An aminobenzoic acid that is anthranilic acid in which one of the hydrogens attached to the nitrogen is replaced by a 2,6-dichloro-3-methylphenyl group. A non-steroidal anti-inflammatory drug, it is used as the sodium salt for the treatment of dysmenorrhoea (painful periods), osteoarthritis and rheumatoid arthritis.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Meclofenamic acid was shown to be a potential antineoplastic agent for both androgen-dependent and androgen-independent prostate cancer." | 1.38 | Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation. ( Baltazar-Rodriguez, LM; Delgado-Enciso, I; Espinoza-Gómez, F; Galvan-Salazar, HR; Gonzalez-Alvarez, R; Guzman-Esquivel, J; Martinez-Martinez, R; Montes-Galindo, DA; Ortiz-Lopez, R; Rodriguez-Hernandez, A; Rojas-Martinez, A; Soriano-Hernández, AD; Valdez-Velazquez, LL, 2012) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Soriano-Hernández, AD | 1 |
| Galvan-Salazar, HR | 1 |
| Montes-Galindo, DA | 1 |
| Rodriguez-Hernandez, A | 1 |
| Martinez-Martinez, R | 1 |
| Guzman-Esquivel, J | 1 |
| Valdez-Velazquez, LL | 1 |
| Baltazar-Rodriguez, LM | 1 |
| Espinoza-Gómez, F | 1 |
| Rojas-Martinez, A | 1 |
| Ortiz-Lopez, R | 1 |
| Gonzalez-Alvarez, R | 1 |
| Delgado-Enciso, I | 1 |
1 other study available for meclofenamic acid and Experimental Neoplasms
| Article | Year |
|---|---|
Antitumor effect of meclofenamic acid on human androgen-independent prostate cancer: a preclinical evaluation.
Topics: Androgens; Animals; Anti-Inflammatory Agents, Non-Steroidal; Disease Progression; Dose-Response Rela | 2012 |